Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A1C declined by up to an average of 1.6% in TRIUMPH-2
However, achieving the peak of your desired results may require multiple treatments
[1] Important safety considerations include a boxed warning for thyroid C-cell tumors (medullary thyroid carcinoma/MEN2), and warnings for pancreatitis and gallbladder disease
10.1172/jci.insight.93382 Summary Keywords glucagon-like peptide-1 receptor agonists, ocular diseases, glaucoma, diabetic retinopathy, mechanism Citation Xie Z, Yang Z, Tian D and Chen Y (2025) Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
US$ 27.23
US$ 21.52
US$ 25.61
US$ 23.52
US$ 24.01
